tiprankstipranks
FDA accepts Bristol Myers’ sBLA for Opdivo plus Yervoy
PremiumThe FlyFDA accepts Bristol Myers’ sBLA for Opdivo plus Yervoy
27d ago
Bristol-Myers Squibb: Balancing Growth and Challenges Amidst Market Dynamics – A Hold Recommendation
Premium
Ratings
Bristol-Myers Squibb: Balancing Growth and Challenges Amidst Market Dynamics – A Hold Recommendation
1M ago
Bristol-Myers Squibb: Promising Growth Amidst Legacy Challenges and Policy Headwinds
Premium
Ratings
Bristol-Myers Squibb: Promising Growth Amidst Legacy Challenges and Policy Headwinds
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100